查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1808916

弓形虫病检测市场，按产品类型、按检测类型、按技术、按样本类型、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Toxoplasmosis Testing Market, By Product Type, By Test Type, By Technology, By Sample Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 398 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年弓形虫病检测市场规模价值 12.67 亿美元，2025 年至 2032 年的复合年增长率为 9.1%。

弓形虫病检测市场涉及检测弓形虫感染的诊断程序，主要透过血清学和分子检测。市场成长的动力源自于免疫功能低下患者、孕妇和器官移植接受者中弓形虫病病例的增加，尤其是在卫生条件和意识薄弱的地区。产前筛检计画的兴起（尤其是在欧洲和南美洲）以及核酸扩增检测 (NAAT) 在诊断实验室中的应用正在提振需求。然而，市场也面临诸如漏报、公共卫生监测不足以及低收入地区检测实务不一致等限制因素。在机会方面，不断增长的研发资金、PCR 和 ELISA 平台的技术改进以及诊断公司与公共卫生机构（例如美国疾病管制与预防中心和世界卫生组织）之间的合作预计将在未来几年支持市场扩张。

弓形虫病检测市场-市场动态

产前筛检和诊断技术的进步推动弓形虫病检测市场成长

由于人们越来越重视产前护理和传染病管理，弓形虫病检测市场发展势头强劲。根据美国疾病管制与预防中心 (CDC) 统计，美国有超过 4,000 万人感染弓形虫病，但大多数患者没有症状。孕妇和免疫功能低下者尤其容易感染，因此法国、奥地利和巴西等国家製定了定期筛检方案。 2023 年，欧洲疾病预防控制中心 (ECDC) 强调，东欧正在加强宣传活动并改善诊断方法，以减少先天性感染。同时，世界卫生组织 (WHO) 在食源性寄生虫疾病方面的努力也促进了公共卫生策略的改进，尤其是在发展中国家。诊断实验室和医院之间日益加强的合作，例如在公共卫生诊所进行标准化血清学检测，也促进了市场扩张。

弓形虫病检测市场-关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 9.1%。

根据产品类型细分，预计检测试剂盒将在 2024 年占据最大市场份额

根据检测类型细分，血清学检测是 2024 年的主要检测类型

根据技术细分，酵素连结免疫吸附试验 (ELISA) 是 2024 年的领先技术

根据样本类型细分，血液是 2024 年的主要样本类型

根据最终用户细分，医院是 2024 年的主要最终用户

按地区划分，北美是 2024 年的主要收入来源

弓形虫病检测市场-細項分析：

全球弓形虫病检测市场根据产品类型、检测类型、技术、样本类型、最终用户和地区进行细分。

根据产品类型，市场分为四类：检测试剂盒、试剂、仪器和分析仪以及软体解决方案。检测试剂盒因其在临床和即时诊断中的广泛应用而占据最高优先级。试剂紧随其后，受持续性需求的推动。仪器和分析仪排名第二，而软体解决方案在结果解读中发挥着支持性但新兴的作用。

根据检测类型，市场分为三类：血清学检测、分子检测、组织学检测和其他。血清学检测因其成本效益高且临床应用广泛而占据市场主导地位。分子检测紧随其后，其在参考实验室的应用日益增加。组织学检测的受欢迎程度较低，而其他类型的检测市占率则微乎其微。

弓形虫病检测市场-地理洞察

在欧洲，法国和奥地利等国家已实施常规产前弓形虫病筛检计划，显着提高了早期诊断率并推动了市场发展。根据欧洲疾病预防控制中心 (ECDC) 的数据，先天性弓形虫病仍然是公共卫生策略的重点，尤其是在感染率较高的东欧。在北美，美国疾病管制与预防中心 (CDC) 与公共卫生部门和诊断实验室合作，提高对孕妇和免疫功能低下人群的认识并进行预防性检测。在巴西，卫生部在其先天性感染控制计画下加强了弓形虫病监测，提高了公立医院诊断服务的可近性。据报道，2024 年，巴西和阿根廷的大学医院与诊断试剂供应商合作，以推进在地化血清学研发。这些针对特定地区的措施和机构联盟正在稳步促进全球医疗体系对弓形虫病的检测和控制。

弓形虫病检测市场-竞争格局：

弓形虫病检测市场竞争适中，多家诊断公司和研究机构致力于提高检测灵敏度和可负担性。 Bio-Rad Laboratories、雅培和DiaSorin等主要参与者正与学术机构和公共卫生机构合作，持续推动血清学检测方法的开发。 2024年，DiaSorin与米兰大学合作，改进IgG亲和力检测，以便在怀孕早期检测弓形虫病。同样，巴斯德研究所与法国的诊断新创公司合作，支持资源匮乏地区的快速检测试剂盒创新。同时，雅培扩展了其分子诊断部门，整合了病原体特异性PCR平台，以涵盖包括弓形虫在内的寄生虫感染。在区域层面，巴西的Fiocruz公司与当地生物技术公司合作生产ELISA检测试剂盒，以减少对进口诊断试剂的依赖。此类策略联盟和公私合作伙伴关係正在加强全球检测基础设施，并加速采用更高效的弓形虫病诊断方法。

最新动态：

2024年5月，芝加哥大学和LDBIO Diagnostics公司推出了一种快速即时检测方法－弓形虫ICT IgG-IgM，只需刺破手指，30分钟内即可进行准确检测，灵敏度超过97.5%，特异性达到100%，有效降低假阳性率，提高产前筛检准确度。

2025 年 5 月，海得拉巴国家动物生物技术研究所 (NIAB) 的科学家利用基于 CRISPR 的基因操作技术精确定位了一种弓形虫蛋白，这种蛋白可能是预防人畜共患疾病传播和先天性弓形虫病的关键——这项工作与世界卫生组织和粮农组织在食源性寄生虫病粮农组织方面的优先事项相一致。

目录

第一章：弓形虫病检测市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 弓浆虫病检测市场片段（依产品类型）
    • 弓浆虫病检测市场片段（依检测类型）
    • 弓浆虫病检测市场（依技术）
    • 弓浆虫病检测市场片段（依样本类型）
    • 弓形虫病检测市场片段（按最终用户）
    • 弓形虫病检测市场（按国家/地区）
    • 弓形虫病检测市场（按地区）
  • 竞争洞察

第三章：弓形虫病检测主要市场趋势

  • 弓形虫病检测市场驱动因素
    • 市场驱动因素的影响分析
  • 弓形虫病检测市场限制
    • 市场限制的影响分析
  • 弓形虫病检测市场机会
  • 弓形虫病检测市场未来趋势

第四章：弓形虫病检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：弓形虫病检测市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：弓形虫病检测市场格局

  • 2024年弓浆虫病检测市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：弓形虫病检测市场－依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 测试套件
    • 试剂
    • 仪器和分析仪
    • 软体解决方案

第八章：弓形虫病检测市场－依检测类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 血清学检测
    • 分子检测
    • 组织学检查
    • 其他

第九章：弓形虫病检测市场－按技术

  • 概述
    • 按技术细分的市场份额分析
    • 酵素连结免疫吸附试验（ELISA）
    • 聚合酶炼式反应（PCR）
    • 其他的

第十章：弓形虫病检测市场－依样本类型

  • 概述
    • 依样本类型进行细分份额分析
    • 血
    • 羊水
    • 脑脊髓液
    • 其他体液

第 11 章：弓形虫病检测市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 诊断实验室
    • 研究机构
    • 家庭护理设置

第 12 章：弓形虫病检测市场 - 按地域划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美弓形虫病检测主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按样本类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲弓形虫病检测主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模及预测（依样本类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区弓形虫病检测主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（依测试类型）
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区市场规模及预测（依样本类型）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲弓形虫病检测主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按测试类型）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模及预测（依样本类型）
    • LATAM 规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲弓形虫病检测主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按测试类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按样本类型）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 13 章：弓形虫病检测产业主要供应商分析

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Abbott Laboratories
    • ARUP Laboratories
    • Becton, Dickinson and Company
    • bioMerieux
    • Bio-Rad Laboratories
    • Creative Diagnostics
    • Danaher Corporation
    • DiaSorin
    • F. Hoffmann-La Roche
    • Luminex Corporation
    • NovaTec Immundiagnostica
    • Omega Diagnostics
    • Ortho Clinical Diagnostics
    • QIAGEN
    • Randox Laboratories
    • Siemens Healthineers
    • Thermo Fisher Scientific
    • Trinity Biotech
    • Vircell
    • ZEUS Scientific
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5567

Toxoplasmosis Testing Market size was valued at US$ 1,267 Million in 2024, expanding at a CAGR of 9.1% from 2025 to 2032.

The Toxoplasmosis Testing Market involves diagnostic procedures to detect Toxoplasma gondii infection, primarily through serological and molecular tests. Market growth is driven by increasing cases of toxoplasmosis in immunocompromised patients, pregnant women, and organ transplant recipients, especially in regions with limited sanitation and awareness. Rising prenatal screening initiatives, particularly in Europe and South America, and the use of nucleic acid amplification tests (NAATs) in diagnostic labs are bolstering demand. However, the market faces restraints such as underreporting, limited public health surveillance, and inconsistent testing practices in low-income regions. On the opportunity front, growing R&D funding, technological improvements in PCR and ELISA platforms, and collaborations between diagnostic companies and public health agencies (e.g., CDC and WHO) are expected to support market expansion over the coming years.

Toxoplasmosis Testing Market- Market Dynamics

Rising Prenatal Screening and Diagnostic Advancements Fuel Toxoplasmosis Testing Market Growth

The toxoplasmosis testing market is gaining momentum due to the increasing emphasis on prenatal care and infectious disease management. According to the CDC, toxoplasmosis affects over 40 million people in the U.S., though most remain asymptomatic. Pregnant women and immunocompromised individuals are particularly at risk, prompting regular screening protocols in countries like France, Austria, and Brazil. In 2023, the European Centre for Disease Prevention and Control (ECDC) highlighted rising awareness campaigns and improved diagnostics in Eastern Europe to reduce congenital infections. Simultaneously, initiatives like the WHO's efforts on foodborne parasitic diseases have led to improved public health strategies, especially in developing nations. Growing collaborations between diagnostic labs and hospitals, such as standardized serological testing in public health clinics, are also contributing to market expansion.

Toxoplasmosis Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2025-2032)

Based on product type segmentation, Test kits were predicted to show maximum market share in the year 2024

Based on Test Type segmentation, Serological tests were the leading Test Type in 2024

Based on Technology segmentation, Enzyme-Linked Immunosorbent Assay (ELISA) was the leading Technology in 2024

Based on Sample Type segmentation, Blood was the leading Sample Type in 2024

Based on end user segmentation, Hospitals were the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Toxoplasmosis Testing Market- Segmentation Analysis:

The Global Toxoplasmosis Testing Market is segmented on the basis of Product Type, Test Type, Technology, Sample Type, End User, and Region.

The market is divided into four categories based on product type: Test Kits, Reagents, Instruments and Analyzers, and Software Solutions. Test kits held the highest priority due to their widespread use in clinical and point-of-care diagnostics. Reagents followed, driven by recurring demand. Instruments and analyzers ranked next, while software solutions held a supportive yet emerging role in result interpretation.

The market is divided into three categories based on Test Type: Serological Tests, Molecular Tests, Histological Tests, and Other. Serological tests led the market due to their cost-effectiveness and broad clinical use. Molecular tests followed closely with rising adoption in reference labs. Histological tests were less preferred, while other test types held minimal market share.

Toxoplasmosis Testing Market- Geographical Insights

In Europe, countries such as France and Austria have implemented routine prenatal toxoplasmosis screening programs, significantly boosting early diagnosis and driving market development. According to the European Centre for Disease Prevention and Control (ECDC), congenital toxoplasmosis remains a critical focus in public health strategies, especially in Eastern Europe, where infection rates are higher. In North America, the CDC promotes awareness and preventive testing among pregnant women and immunocompromised individuals, supported by collaborations with public health departments and diagnostic labs. In Brazil, the Ministry of Health has strengthened toxoplasmosis surveillance under its congenital infection control program, enhancing access to diagnostic services in public hospitals. In 2024, collaborations between university hospitals and diagnostic reagent providers were reported in Brazil and Argentina to advance localized serology development. These region-specific initiatives and institutional alliances are steadily contributing to the improved detection and control of toxoplasmosis across global healthcare systems.

Toxoplasmosis Testing Market- Competitive Landscape:

The toxoplasmosis testing market is moderately competitive, with several diagnostic firms and research institutions focused on enhancing test sensitivity and affordability. Key players like Bio-Rad Laboratories, Abbott, and DiaSorin continue to advance serological assay development in collaboration with academic and public health institutions. In 2024, DiaSorin partnered with the University of Milan to refine IgG avidity testing for early toxoplasmosis detection in pregnancy. Similarly, the Pasteur Institute has collaborated with diagnostic startups in France to support rapid test kit innovation for low-resource settings. Meanwhile, Abbott expanded its molecular diagnostics division by integrating pathogen-specific PCR platforms to cover parasitic infections, including T. gondii. On the regional level, Brazil's Fiocruz has worked with local biotech firms to produce ELISA test kits, reducing reliance on imported diagnostics. Such strategic alliances and public-private partnerships are strengthening the global testing infrastructure and accelerating the adoption of more efficient toxoplasmosis diagnostics.

Recent Developments:

In May 2024, the University of Chicago and LDBIO Diagnostics introduced a rapid point-of-care test, the Toxoplasma ICT IgG-IgM, offering accurate detection within 30 minutes from a finger-prick, with over 97.5% sensitivity and 100% specificity, effectively reducing false positives and improving prenatal screening accuracy.

In May 2025, scientists at the National Institute of Animal Biotechnology (NIAB) in Hyderabad used CRISPR-based genetic manipulation to pinpoint a Toxoplasma gondii protein that could be key in preventing zoonotic transmission and congenital toxoplasmosis-an effort aligned with WHO and FAO priorities on foodborne parasitic diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TOXOPLASMOSIS TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • ARUP Laboratories
  • Becton, Dickinson and Company
  • bioMerieux
  • Bio-Rad Laboratories
  • Creative Diagnostics
  • Danaher Corporation
  • DiaSorin
  • F. Hoffmann-La Roche
  • Luminex Corporation
  • NovaTec Immundiagnostica
  • Omega Diagnostics
  • Ortho Clinical Diagnostics
  • QIAGEN
  • Randox Laboratories
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Trinity Biotech
  • Vircell
  • ZEUS Scientific
  • Others

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Test Kits
  • Reagents
  • Instruments and Analyzers
  • Software Solutions

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Serological Tests
  • Molecular Tests
  • Histological Tests
  • Other

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR)
  • Others

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Blood
  • Amniotic Fluid
  • Cerebrospinal Fluid
  • Other

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions
  • Homecare Settings

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Toxoplasmosis Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Toxoplasmosis Testing Market Snippet by Product Type
    • 2.1.2. Toxoplasmosis Testing Market Snippet by Test Type
    • 2.1.3. Toxoplasmosis Testing Market Snippet by Technology
    • 2.1.4. Toxoplasmosis Testing Market Snippet by Sample Type
    • 2.1.5. Toxoplasmosis Testing Market Snippet by End User
    • 2.1.6. Toxoplasmosis Testing Market Snippet by Country
    • 2.1.7. Toxoplasmosis Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Toxoplasmosis Testing Key Market Trends

  • 3.1. Toxoplasmosis Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Toxoplasmosis Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Toxoplasmosis Testing Market Opportunities
  • 3.4. Toxoplasmosis Testing Market Future Trends

4. Toxoplasmosis Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Toxoplasmosis Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Toxoplasmosis Testing Market Landscape

  • 6.1. Toxoplasmosis Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Toxoplasmosis Testing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Test Kits
    • 7.1.3. Reagents
    • 7.1.4. Instruments and Analyzers
    • 7.1.5. Software Solutions

8. Toxoplasmosis Testing Market - By Test Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 8.1.2. Serological Tests
    • 8.1.3. Molecular Tests
    • 8.1.4. Histological Tests
    • 8.1.5. Other

9. Toxoplasmosis Testing Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 9.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 9.1.3. Polymerase Chain Reaction (PCR)
    • 9.1.4. Others

10. Toxoplasmosis Testing Market - By Sample Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
    • 10.1.2. Blood
    • 10.1.3. Amniotic Fluid
    • 10.1.4. Cerebrospinal Fluid
    • 10.1.5. Other Body Fluids

11. Toxoplasmosis Testing Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Diagnostic Laboratories
    • 11.1.4. Research Institutions
    • 11.1.5. Homecare Settings

12. Toxoplasmosis Testing Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Toxoplasmosis Testing Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Toxoplasmosis Testing Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Toxoplasmosis Testing Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Toxoplasmosis Testing Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Toxoplasmosis Testing Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Toxoplasmosis Testing Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. ARUP Laboratories
    • 13.2.3. Becton, Dickinson and Company
    • 13.2.4. bioMerieux
    • 13.2.5. Bio-Rad Laboratories
    • 13.2.6. Creative Diagnostics
    • 13.2.7. Danaher Corporation
    • 13.2.8. DiaSorin
    • 13.2.9. F. Hoffmann-La Roche
    • 13.2.10. Luminex Corporation
    • 13.2.11. NovaTec Immundiagnostica
    • 13.2.12. Omega Diagnostics
    • 13.2.13. Ortho Clinical Diagnostics
    • 13.2.14. QIAGEN
    • 13.2.15. Randox Laboratories
    • 13.2.16. Siemens Healthineers
    • 13.2.17. Thermo Fisher Scientific
    • 13.2.18. Trinity Biotech
    • 13.2.19. Vircell
    • 13.2.20. ZEUS Scientific
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us